Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPhysics, Instrumentation & Data Sciences - Data Sciences

Machine Learning and Radiomics-based Classification of Thyroid Disease Using 99mTc-Pertechnetate Scintigraphy

Maziar Sabouri, Atlas Haddadi Avval, Soroush Bagheri, Azin Asadzadeh, Mohaddese Sehati, Mahdi Mogharrabi, Maryam Arefnia, Fereshteh Yousefirizi, Ghasem Hajianfar, Habib Zaidi and Arman Rahmim
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242315;
Maziar Sabouri
1Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atlas Haddadi Avval
2Mashhad University of Medical Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soroush Bagheri
3Department of Medical Physics, Kashan University of Medical Sciences, Kashan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azin Asadzadeh
4Department of nuclear medicine, 5azar hospital, Golestan university of medical sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohaddese Sehati
5Department of nuclear medicine, 5 azar hospital, Golestan university of medical sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahdi Mogharrabi
6Department of nuclear medicine , 5Azar hospital, Golestone university of medical science, Gorgan , Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Arefnia
7Shahidbeheshti university of medical science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fereshteh Yousefirizi
8BCCRC/UBC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ghasem Hajianfar
9Division of Nuclear medicine and Molecular Imaging, Geneva University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Habib Zaidi
10Geneva University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arman Rahmim
11University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

242315

Introduction: Nuclear medicine plays a key role in the diagnosis and differentiation of thyroid pathologies. Currently, in addition to subjective 99mTc-Pertechtenate scintigraphy image assessments, physicians might utilize the absolute counts of thyroid uptake, based on the uptake values derived from pre- and post-injection of syringe, injection site, thyroid, and background images, for diagnosis ranging from normal tissue to thyroiditis and nodular goiter. In this study, we aimed to provide an AI-assisted model in conjunction with radiomic features to distinguish pathological from healthy cases, using only thyroid images.

Methods: We retrospectively collected thyroid scintigraphy imaging data from 191 patients. The ground truth was based on thyroid uptake used by nuclear medicine physician for clinical diagnosis (50 diffuse goiter, 29 multinodular goiter, 41 thyroiditis, and 71 normal). One representative sample of each class can be seen in Figure 1. A total of 100 radiomic features (shape, intensity, and second-/high-order texture features from Gray Level Dependence Matrix (GLDM), Gray Level Co-occurrence Matrix (GLCM), Gray Level Run Length Matrix (GLRLM), Gray Level Size Zone Matrix (GLSZM), and Neighboring Gray Tone Difference Matrix (NGTDM)) were extracted using the Pyradiomics python library from segmented thyroids in antero-posterior scintigraphic images. Using nested cross-validation (outer and inner loops of 5 and 4, respectively), one to ten of the most predictive feature combinations were selected iteratively via the Minimum Redundancy Maximum Relevance (MRMR) algorithm. In each fold, the feature(s) were subsequently fed to machine learning (ML) models for binary classification task (normal vs. abnormal). We utilized 8 ML algorithms, including (Random Forest (RF), Naive Bayesian (NB), Decision Tree (DT), eXtreme Gradient Boosting (XGB), Multilayer Perceptron (MLP), Logistic Regression (LR), Support Vector Machine (SVM), and K-Nearest Neighbors (KNN)). Metrics including area under the receiver operating characteristic curve (AUC-ROC), accuracy (ACC), and F1-score were reported.

Results: Our results demonstrated that the top 5 most selected features in the entire feature selection process were Coarseness and Strength (from NGTDM features), Maximum_2D_Diameter_Column (from shape features), Informational Measure of Correlation 2 (Imc2) (from GLCM features), and Gray_Level_Variance (from GLSZM features). The results of all models are illustrated in Figure 2. Among ML classifiers, the best-performing model according to AUC was DT (AUC=0.809 ± 0.081, ACC=0.785 ± 0.091, F1=0.802 ± 0.092, using most predictive combination of 6 features), and the best accuracy and F1-score were achieved by RF (ACC=0.790 ± 0.077, F1=0.835 ± 0.059, AUC=0.773 ± 0.084, using most predictive combination of 10 features).

Conclusions: Our study demonstrated that ML algorithms coupled with radiomic features are reasonably capable of differentiating healthy cases from patients with thyroid disease only from thyroid images without the need for calculating uptake values, which can be time-saving and effectively contribute to daily clinical practice. Moreover, the streamlined process eliminates the need for pre- and post-injection imaging of syringe, injection site imaging, and background imaging, thereby decreasing the workload and radiation exposure to staff.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Machine Learning and Radiomics-based Classification of Thyroid Disease Using 99mTc-Pertechnetate Scintigraphy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Machine Learning and Radiomics-based Classification of Thyroid Disease Using 99mTc-Pertechnetate Scintigraphy
Maziar Sabouri, Atlas Haddadi Avval, Soroush Bagheri, Azin Asadzadeh, Mohaddese Sehati, Mahdi Mogharrabi, Maryam Arefnia, Fereshteh Yousefirizi, Ghasem Hajianfar, Habib Zaidi, Arman Rahmim
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242315;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Machine Learning and Radiomics-based Classification of Thyroid Disease Using 99mTc-Pertechnetate Scintigraphy
Maziar Sabouri, Atlas Haddadi Avval, Soroush Bagheri, Azin Asadzadeh, Mohaddese Sehati, Mahdi Mogharrabi, Maryam Arefnia, Fereshteh Yousefirizi, Ghasem Hajianfar, Habib Zaidi, Arman Rahmim
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242315;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • PET-Disentangler: PET lesion segmentation via disentangled healthy and disease feature representations
  • Comparative analysis of large language models: ChatGPT and Google Bard answer non-expert questions related to the diagnostic and therapeutic applications of prostate-specific membrane antigen (PSMA) in patients with prostate cancer
  • Prediction of Standard-Dose Brain 18F-Flortaucipir PET Images via Implicit Neural Networks
Show more Physics, Instrumentation & Data Sciences - Data Sciences

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire